Literature DB >> 15028751

Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Pedro Gonzalez-Alegre1, Henry L Paulson.   

Abstract

Torsion dystonia-1 (DYT1) dystonia, the most common inherited form of dystonia, is caused by a three base pair deletion that eliminates a single amino acid from the disease protein, torsinA. TorsinA is an "AAA" protein thought to reside in the endoplasmic reticulum (ER), yet both its cellular function and the basis for neuronal dysfunction in DYT1 remain unknown. A clue to disease pathogenesis is the fact that mutant, but not wild-type, torsinA forms membranous inclusions in cell culture. To explore the pathobiology of DYT1 dystonia, we generated PC12 neural cell lines that inducibly express wild-type or mutant torsinA. Although in this model torsinA displays some properties consistent with ER localization, mutant torsinA also accumulates in the nuclear envelope (NE), a structure contiguous with cytoplasmic ER. Consistent with this, membranous inclusions formed by mutant torsinA are shown to derive not from the ER, as thought previously, but from the NE. We demonstrate further that torsinA forms different disulfide-linked complexes that may be linked functionally to subcellular localization in the NE versus cytoplasmic ER. Despite mutant TA accumulation in NE structures, nucleocytoplasmic transport of a reporter protein was unaffected. These findings, together with parallel studies failing to demonstrate perturbation of ER function, implicate the NE as a primary site of dysfunction in DYT1. DYT1 dystonia can be added to the growing list of inherited neurological disorders involving the NE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028751      PMCID: PMC6729521          DOI: 10.1523/JNEUROSCI.4461-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.

Authors:  M D Galigniana; C Radanyi; J M Renoir; P R Housley; W B Pratt
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

2.  Immunohistochemical localization and distribution of torsinA in normal human and rat brain.

Authors:  P Shashidharan; B C Kramer; R H Walker; C W Olanow; M F Brin
Journal:  Brain Res       Date:  2000-01-24       Impact factor: 3.252

3.  Formation of intranuclear crystalloids and proliferation of the smooth endoplasmic reticulum in schwann cells induced by tellurium treatment: association with overexpression of HMG CoA reductase and HMG CoA synthase mRNA.

Authors:  M T Berciano; R Fernandez; E Pena; E Calle; N T Villagra; J C Rodriguez-Rey; M Lafarga
Journal:  Glia       Date:  2000-02-01       Impact factor: 7.452

4.  Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations.

Authors:  K Kustedjo; M H Bracey; B F Cravatt
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

5.  Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.

Authors:  Y Chai; S L Koppenhafer; N M Bonini; H L Paulson
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

6.  Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.

Authors:  M K Perez; H L Paulson; R N Pittman
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

7.  Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.

Authors:  J Hewett; C Gonzalez-Agosti; D Slater; P Ziefer; S Li; D Bergeron; D J Jacoby; L J Ozelius; V Ramesh; X O Breakefield
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

8.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.

Authors:  Y Chai; S L Koppenhafer; S J Shoesmith; M K Perez; H L Paulson
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

9.  Live fluorescence imaging reveals early recruitment of emerin, LBR, RanBP2, and Nup153 to reforming functional nuclear envelopes.

Authors:  T Haraguchi; T Koujin; T Hayakawa; T Kaneda; C Tsutsumi; N Imamoto; C Akazawa; J Sukegawa; Y Yoneda; Y Hiraoka
Journal:  J Cell Sci       Date:  2000-03       Impact factor: 5.285

10.  A visual screen of a GFP-fusion library identifies a new type of nuclear envelope membrane protein.

Authors:  M M Rolls; P A Stein; S S Taylor; E Ha; F McKeon; T A Rapoport
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  74 in total

Review 1.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 3.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 4.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 5.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

6.  Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled-coil domain.

Authors:  Cem Sengel; Sophie Gavarini; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

7.  Arresting a Torsin ATPase reshapes the endoplasmic reticulum.

Authors:  April E Rose; Chenguang Zhao; Elizabeth M Turner; Anna M Steyer; Christian Schlieker
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

8.  Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia.

Authors:  Nicole Calakos; Viren D Patel; Melissa Gottron; Gaofeng Wang; Khan-Nhat Tran-Viet; Danielle Brewington; John L Beyer; David C Steffens; Ranga R Krishnan; Stephan Züchner
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

9.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

10.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Authors:  Chun-Chi Liang; Lauren M Tanabe; Stephanie Jou; Frank Chi; William T Dauer
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.